首页> 外国专利> METHOD FOR DETERMINING localization of pathological process at chronic dysfunction of renal allograft

METHOD FOR DETERMINING localization of pathological process at chronic dysfunction of renal allograft

机译:确定慢性移植肾功能不全患者病理过程定位的方法

摘要

A method for determining the localization of the pathological process at chronic renal allograft dysfunction involves obtaining blood samples of renal allograft recipients at the late postoperative period and determining the concentration of beta-2 microglobulin in blood serum and creatinine concentration and beta-2-microglobulin in morning urine samples. When the level of blood serum is creatinine 150 umol / l with the concentration of beta-2-microglobulin in serum of 8.55 mcg / ml chronic renal allograft dysfunction is determined with primary glomerular affection. When the level of blood serum creatinine is 150 umol / l with the concentration of beta-2-microglobulin / creatinine in urine 0.18 mcg / ml / mM / l chronic renal allograft dysfunction with primary tubular affection is stated.
机译:确定慢性肾脏同种异体移植功能障碍的病理过程定位的方法包括在术后后期获取肾脏同种异体移植受者的血液样本,并测定血清中β2微球蛋白的浓度和肌酐浓度以及β2-微球蛋白的浓度。早晨尿样。当血清肌酐水平为150 umol / l,且血清中β-2-微球蛋白的浓度> 8.55 mcg / ml时,可确定是原发性肾小球病变引起的慢性肾移植功能障碍。当血清肌酐水平为150 umol / l,尿液中β-2-微球蛋白/肌酐的浓度> 0.18 mcg / ml / mM / l时,提示慢性肾移植肾功能不全伴原发性肾小管病变。

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号